Lots of investors have been looking closely at what is happening at Wockhardt for the last few months.
The parallels between the Ranbaxy story and the Wockhardt story is too hard to miss!!
A great article http://features.blogs.fortune.cnn.com/2013/05/15/ranbaxy-fraud-lipitor/ on Ranbaxy was published by fortune and is a must read for all Pharma investors.
A prime case as to why management quality is important for investing in India
The parallels between the Ranbaxy story and the Wockhardt story is too hard to miss!!
A great article http://features.blogs.fortune.cnn.com/2013/05/15/ranbaxy-fraud-lipitor/ on Ranbaxy was published by fortune and is a must read for all Pharma investors.
A prime case as to why management quality is important for investing in India
No comments:
Post a Comment